publicações selecionadas
-
artigo académico
- Cadherin-3 is a novel oncogenic biomarker with prognostic value in glioblastoma. Molecular Oncology. 2022
- Cadherin switches during epithelial-mesenchymal transition: CDH4/RCAD downregulation reduces bladder cancer progression. Cellular Oncology. 2022
- The T-box transcription factor brachyury behaves as a tumor suppressor in gliomas. Journal of Pathology. 2020
- In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas.. Translational Oncology. 2013
-
artigo de revista
- MCT1 Is a New Prognostic Biomarker and Its Therapeutic Inhibition Boosts Response to Temozolomide in Human Glioblastoma. Cancers. 2021
- Sirtuins' Deregulation in Bladder Cancer: SIRT7 Is Implicated in Tumor Progression through Epithelial to Mesenchymal Transition Promotion. Cancers. 2020
- Euphol, a tetracyclic triterpene, from Euphorbia tirucalli induces autophagy and sensitizes temozolomide cytotoxicity on glioblastoma cells. Investigational New Drugs. 2019
- Internalization studies on zeolite nanoparticles using human cells. Journal of Materials Chemistry B. 2018
- Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk. Molecular Carcinogenesis. 2017
- Monocarboxylate transporter 1 is a key player in glioma-endothelial cell crosstalk. Molecular Carcinogenesis. 2017
- Metabolic alterations underlying Bevacizumab therapy in glioblastoma cells. Oncotarget. 2017
- Alginate hydrogel improves anti-angiogenic bevacizumab activity in cancer therapy. European Journal of Pharmaceutics and Biopharmaceutics. 2017
- HER Family Receptors are Important Theranostic Biomarkers for Cervical Cancer: Blocking Glucose Metabolism Enhances the Therapeutic Effect of HER Inhibitors. Theranostics. 2017
- Hypoxia-mediated upregulation of MCT1 expression supports the glycolytic phenotype of glioblastomas. Oncotarget. 2016
- Lactate transporters and pH regulation: potential therapeutic targets in glioblastomas.. Current Cancer Drug Targets. 2015
- Monocarboxylate transport inhibition potentiates the cytotoxic effect of 5-fluorouracil in colorectal cancer cells. Cancer Letters. 2015
- Antitumoural and antiangiogenic activity of Portuguese propolis in in vitro and in vivo models. Journal of Functional Foods. 2014
- Differential sensitivities to lactate transport inhibitors of breast cancer cell lines. Endocrine-Related Cancer. 2013
- Portuguese propolis disturbs glycolytic metabolism of human colorectal cancer in vitro. BMC Complementary and Alternative Medicine. 2013
- In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas. Translational Oncology. 2013
- Monocarboxylate transporters (MCTs) in gliomas: expression and exploitation as therapeutic targets. Neuro-Oncology. 2013
- The Monocarboxylate Transporter Inhibitor a-Cyano-4-Hydroxycinnamic Acid Disrupts Rat Lung Branching. Cellular Physiology and Biochemistry. 2013
- Downregulation of RKIP Is Associated with Poor Outcome and Malignant Progression in Gliomas. Antibiotics. 2012
- Angiogenic Potential of Gellan-Gum-Based Hydrogels for Application in Nucleus Pulposus Regeneration: In Vivo Study. International Review of Neurobiology. 2012
-
capítulo de livro
-
documento
- EMT impact in bladder cancer progression: understanding the cadherins' role and their regulatory mechanisms 2021
- WNT6 regulation in Glioblastoma: Mechanistic, Functional and Clinical implications 2017
- CDH3/P-cadherin as a putative HOXA9 target in gliomas: functional and clinical relevance 2017
- Blocking glucose metabolism enhances the effect of HER inhibitors in cervical cancer therapy. 2016
- HER receptors are important theranostic biomarkers on cervical cancer: blocking glucose metabolism enhances the therapeutic effect of HER inhibitors. 2016
- Caracterização da actividade antitumoral e angiogénica do própolis português usando modelos in vitro e in vivo 2014
- CD147 and MCT1: Potential partners in bladder cancer aggressiveness and cisplatin resistance 2013